Institute of Social and Preventive Medicine, University of Bern, Switzerland.
Institute of Medical Virology, University of Zürich, Zurich, Switzerland.
Clin Infect Dis. 2023 Aug 22;77(4):537-546. doi: 10.1093/cid/ciab1005.
Vaccination may control the coronavirus disease 2019 (COVID-19) pandemic, including in nursing homes where many high-risk people live. We conducted extensive outbreak investigations.
We studied an outbreak at a nursing home in Switzerland, where the uptake of messenger RNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was 82% among residents as of 21 January 2021. After diagnosis of COVID-19 in a vaccinated symptomatic healthcare worker (HCW) on 22 February, we performed outbreak investigations in house A (47 residents; 37 HCWs), using SARS-CoV-2-specific polymerase chain reaction testing of nasopharyngeal swab samples. We performed whole-genome sequencing of SARS-CoV-2 and serological analyses.
We identified 17 individuals with positive polymerase chain reaction results, 10 residents (5 vaccinated) and 7 HCWs (3 vaccinated). The median age (interquartile range) was 86 (70-90) years among residents and 49 (29-59) years among HCWs. Of the 5 vaccinated residents, 3 had mild disease and 2 had no symptoms, whereas all 5 unvaccinated residents had mild to severe disease, and 2 died. Vaccine effectiveness for the prevention of infection among residents was 73.0% (95% confidence interval, 24.7%-90.1%). The 12 available genomes were all alpha variants. Neutralizing titers were significantly higher in vaccinated individuals on reexposure (>1 week after diagnosis) than in vaccinated, unexposed HCWs (P = .01). Transmission networks indicated 4 likely or possible transmissions from vaccinated to other individuals and 12 transmission events from unvaccinated individuals.
COVID-19 outbreaks can occur in nursing homes, including transmission from vaccinated persons to others. Outbreaks might occur silently, underlining the need for continued testing and basic infection control measures in these high-risk settings.
疫苗接种可控制 2019 年冠状病毒病(COVID-19)大流行,包括居住着许多高危人群的养老院。我们进行了广泛的疫情调查。
我们研究了瑞士一家养老院的疫情,截至 2021 年 1 月 21 日,居民对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)信使 RNA 疫苗的接种率为 82%。在 2 月 22 日接种疫苗的有症状医护人员(HCW)确诊 COVID-19 后,我们对 A 号楼(47 名居民;37 名 HCW)进行了疫情调查,使用 SARS-CoV-2 特异性聚合酶链反应检测鼻咽拭子样本。我们对 SARS-CoV-2 进行了全基因组测序和血清学分析。
我们发现了 17 例聚合酶链反应阳性结果,包括 10 名居民(5 人接种)和 7 名 HCW(3 人接种)。居民的中位年龄(四分位间距)为 86(70-90)岁,HCW 的中位年龄为 49(29-59)岁。在 5 名接种疫苗的居民中,3 人病情较轻,2 人无症状,而所有 5 名未接种疫苗的居民均为轻至重度疾病,其中 2 人死亡。疫苗对居民感染的预防效果为 73.0%(95%置信区间,24.7%-90.1%)。12 个可用基因组均为 alpha 变体。在重新暴露(诊断后>1 周)时,接种疫苗的个体的中和滴度明显高于接种疫苗、未暴露的 HCW(P =.01)。传播网络表明,有 4 例可能或可能从接种者传播到其他人,以及 12 例从未接种者传播的事件。
COVID-19 疫情可发生在养老院,包括接种者向他人传播。疫情可能会悄然发生,这突显了在这些高风险环境中持续进行检测和基本感染控制措施的必要性。